The impact of timing of maternal influenza immunization on infant antibody levels at birth. (2nd December 2018)

• Record Type: Journal Article
• Authors: Zhong, Z; Haltalli, M; Holder, B; Rice, T; Donaldson, B; O'Driscoll, M; Le-Doare, K; Kampmann, B; Tregoning, J S
• Is Part Of: Clinical and experimental immunology. Volume 195:Number 2(2019)
• Page Start: 139
• Page End: 152
• Publication Date: 2018-12-02
• Subjects: human -- vaccination -- viral; Immunopathology -- Periodicals; 616.079
• DOI: 10.1111/cei.13234
• Languages: English
• ISSNs: 0009-9104

Abstract

Summary: Pregnant women and infants are at an increased risk of severe disease after influenza infection. Maternal immunization is a potent tool to protect both these at-risk groups. While the primary aim of maternal influenza vaccination is to protect the mother, a secondary benefit is the transfer of protective antibodies to the infant. A recent study using the tetanus, diphtheria and acellular pertussis (Tdap) vaccine indicated that children born to mothers immunized in the second trimester of pregnancy had the highest antibody titres compared to children immunized in the third trimester. The aim of the current study was to investigate how the timing of maternal influenza immunization impacts infant antibody levels at birth. Antibody titres were assessed in maternal and cord blood samples by both immunoglobulin (Ig)G-binding enzyme-linked immunosorbent assay (ELISA) and haemagglutination inhibition assay (HAI). Antibody titres to the H1N1 component were significantly higher in infants born to mothers vaccinated in either the second or third trimesters than infants born to unvaccinated mothers. HAI levels in the infant were significantly lower when maternal immunization was performed less than 4 weeks before birth. These studies confirm that immunization during pregnancy increases the antibody titre in infants. Importantly, antibody levels in cord blood were significantly higher when the mother was vaccinated in either trimesters 2 or 3, although titres were significantly lower if the mother was immunized less than 4 weeks before birth. Based on these data, seasonal influenza vaccination should continue to be given in pregnancy as soon as it becomes available. Graphical Abstract: